Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls
暂无分享,去创建一个
T. Cooper | M. Oquendo | L. Sher | J. Mann | K. Malone | S. Ellis | B. Brodsky | Shuhua Li
[1] U. Ahlfors,et al. Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression , 1979, Psychopharmacology.
[2] B. Roos,et al. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis , 1972, European Journal of Clinical Pharmacology.
[3] J. A. Boer,et al. Handbook of depression and anxiety , 2003 .
[4] M. Oquendo,et al. Prolactin Response to dl-Fenfluramine Challenge before and after Treatment with Paroxetine , 2001, Neuropsychopharmacology.
[5] S. Leucht,et al. Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[6] N. Craddock,et al. Molecular genetics of bipolar disorder , 2001, British Journal of Psychiatry.
[7] Victoria Arango,et al. The Neurobiology and Genetics of Suicide and Attempted Suicide: A Focus on the Serotonergic System , 2001, Neuropsychopharmacology.
[8] J. Rybakowski,et al. Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. , 2001, Bipolar disorders.
[9] H. Sackeim,et al. ECT in bipolar and unipolar depression: differences in speed of response. , 2001, Bipolar disorders.
[10] W. Drevets. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders , 2001, Current Opinion in Neurobiology.
[11] L. Sher. Genetic studies of seasonal affective disorder and seasonality. , 2001, Comprehensive psychiatry.
[12] Tadafumi Kato,et al. Molecular genetics of bipolar disorder , 1999, Neuroscience Research.
[13] A. Young,et al. Bipolar Disorders : Basic Mechanisms and Therapeutic Implications , 2000 .
[14] M. Fava,et al. Fenfluramine challenge in unipolar depression with and without anger attacks , 2000, Psychiatry Research.
[15] J. Potash,et al. Searching high and low: a review of the genetics of bipolar disorder. , 2000, Bipolar disorders.
[16] G. MacQueen,et al. A two-illness model of bipolar disorder. , 1999, Bipolar disorders.
[17] R. Lam,et al. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls. , 1999, Journal of affective disorders.
[18] John A. Talbott,et al. The American Psychiatric Press textbook of psychiatry , 1999 .
[19] R. Murray,et al. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response , 1998, Biological Psychiatry.
[20] E. Coccaro,et al. Prolactin response to d-fenfluramine in outpatients with major depression , 1998, Psychiatry Research.
[21] S. Kasper,et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. , 1998, Archives of general psychiatry.
[22] L. Siever,et al. Serotonin, aggression, and parental psychopathology in children with attention-deficit hyperactivity disorder. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[23] J. Soares,et al. The anatomy of mood disorders—review of structural neuroimaging studies , 1997, Biological Psychiatry.
[24] E. Coccaro,et al. Hormonal Responses to d- and d,l-Fenfluramine in Healthy Human Subjects , 1996, Neuropsychopharmacology.
[25] T. Dinan,et al. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity. , 1996, The American journal of psychiatry.
[26] R. Murray,et al. Reduced Prolactin and Cortisol Responses to d-Fenfluramine in Depressed Compared to Healthy Matched Control Subjects , 1996, Neuropsychopharmacology.
[27] J. Mann,et al. Prolactin Response to Fenfluramine and Suicide Attempt Lethality in Major Depression , 1996, British Journal of Psychiatry.
[28] J. Mann,et al. Blunted Serotonergic Responsivity in Depressed Inpatients , 1995, Neuropsychopharmacology.
[29] S. Koslow,et al. Depressive mania versus agitated depression: Biogenic amine and hypothalamic-pituitary-adrenocortical function , 1994, Biological Psychiatry.
[30] L. Siever,et al. Familial correlates of reduced central serotonergic system function in patients with personality disorders. , 1994, Archives of general psychiatry.
[31] S. Kish,et al. Cerebral cortex β-adrenoceptor binding in bipolar affective disorder , 1994 .
[32] E. Coccaro,et al. Neuropsychopharmacologic challenge in biological psychiatry. , 1994, Clinical chemistry.
[33] L. Yatham,et al. Neuroendocrine probes of serotonergic function: a critical review. , 1993, Life sciences.
[34] T. Cooper,et al. Hormone responses to fenfluramine and placebo challenge in endogenous depression , 1992, Psychiatry Research.
[35] T. Dinan,et al. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.
[36] G. Mellsop,et al. Platelet tritiated imipramine binding in patients suffering from mania. , 1991, Journal of affective disorders.
[37] G. Cassano,et al. Decreased platelet serotonin uptake in bipolar I patients. , 1991, International clinical psychopharmacology.
[38] D. Charney,et al. Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. , 1991, The American journal of psychiatry.
[39] I. Hickie,et al. Hormonal Responses to Fenfluramine in Depressive Subtypes , 1990, British Journal of Psychiatry.
[40] B. Leonard,et al. Changes in platelet 5-hydroxytryptamine uptake in mania. , 1990, Journal of affective disorders.
[41] G. Aghajanian,et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.
[42] L. Siever,et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. , 1989, Archives of general psychiatry.
[43] J. Sweeney,et al. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. , 1989, Archives of general psychiatry.
[44] Abraham Weizman,et al. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients. , 1988, Clinical neuropharmacology.
[45] Andrew H. Miller,et al. The neuroendocrine response to fenfluramine in depressives and normal controls , 1988, Biological Psychiatry.
[46] R. Kahn,et al. Hormonal probes of central serotonergic activity: Do they really exist? , 1987, Biological Psychiatry.
[47] Gerald L. Brown,et al. Human aggression and suicide. , 1986, Suicide & life-threatening behavior.
[48] M. Åsberg,et al. Therapeutic effects of serotonin uptake inhibitors in depression. , 1986, The Journal of clinical psychiatry.
[49] D. A. Lewis,et al. Tritiated imipramine binding to platelets in manic subjects. , 1985, Journal of affective disorders.
[50] J C Mazziotta,et al. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. , 1985, Archives of general psychiatry.
[51] B. Shaywitz,et al. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. , 1984, The American journal of psychiatry.
[52] D. Charney,et al. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.
[53] H. Meltzer,et al. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. , 1984, Archives of general psychiatry.
[54] D. Murphy,et al. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. , 1984, Life sciences.
[55] M. Åsberg,et al. CSF monoamine metabolites in melancholia , 1984, Acta psychiatrica Scandinavica.
[56] E. Robins,et al. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. , 1984, Archives of general psychiatry.
[57] S. Koslow,et al. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. , 1983, Archives of general psychiatry.
[58] J. Mann,et al. Altered platelet serotonin uptake kinetics in schizophrenia and depression. , 1982, Life sciences.
[59] David M. Martin,et al. DISTINGUISHING UNIPOLAR AND BIPOLAR DEPRESSION BY THYROTROPIN RELEASE TEST , 1979, The Lancet.
[60] N. Nicolaou,et al. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders , 1978, Acta psychiatrica Scandinavica.
[61] F. Goodwin,et al. Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites. , 1977, The American journal of psychiatry.
[62] H. W. Reading,et al. Memberane ATPase activities in depressive illness , 1977, Journal of neurochemistry.
[63] C. Bánki. Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders , 1977, Journal of neurochemistry.
[64] Ashcroft Gw,et al. Mood and neuronal functions: a modified amine hypothesis for the etiology of affective illness. , 1974 .
[65] A. Prange,et al. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. , 1974, Archives of general psychiatry.
[66] F. Goodwin,et al. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. , 1973, The American journal of psychiatry.
[67] P. Whybrow,et al. Abnormalities of indoleamines in affective disorders. , 1972, Archives of general psychiatry.
[68] J. Mendels,et al. Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients , 1972, Science.
[69] G. Heninger,et al. Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. , 1969, International journal of neuropharmacology.
[70] U. Malm,et al. ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA , 1966, Journal of neurochemistry.
[71] J. B. Stanton,et al. 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. , 1966, Lancet.
[72] E. Barratt,et al. Factor Analysis of Some Psychometric Measures of Impulsiveness and Anxiety , 1965, Psychological reports.
[73] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[74] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.